Stocksigma LogoStocksigma Logo

Ipca Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 2,910 (+13.8% YoY | +4.4% QoQ) ■ EBITDA: 673 (+23.6% YoY | +0.6% QoQ) ■ EBITDA Margin (%): 23.1 (+183 bps YoY | -87 bps QoQ) ■ PAT: 375 (+32.8%

Ipca Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Ipca Laboratories Ltd · Outcome · 05 Nov 2026, 7:15 pm

Ipca Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 2,910 (+13.8% YoY | +4.4% QoQ) ■ EBITDA: 673 (+23.6% YoY | +0.6% QoQ) ■ EBITDA Margin (%): 23.1 (+183 bps YoY | -87 bps QoQ) ■ PAT: 375 (+32.8% YoY | -6.7% QoQ) ■ EPS (INR): 15.3 (+23.8% YoY | -3.5% QoQ)

Original exchange filing (PDF)

More announcements from Ipca Laboratories Ltd

All Ipca Laboratories Ltd announcements